HUTCHMED (China) Ltd SEC filings HCM

HUTCHMED (China) Ltd has 611 filings in SEC EDGAR's recent list, going back to Aug 21, 2015. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 5, 2026.

Form Description Filed Period
20-F Annual report (foreign issuer) Mar 5, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Mar 19, 2025 Dec 31, 2024
20-F Annual report (foreign issuer) Feb 28, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Feb 28, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Mar 3, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 4, 2021 Dec 31, 2020
20-F/A Amended annual report (foreign issuer) Apr 29, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) Mar 3, 2020 Dec 31, 2019
20-F/A Amended annual report (foreign issuer) May 30, 2019 Dec 31, 2018
20-F/A Amended annual report (foreign issuer) May 2, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 11, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Mar 12, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) Mar 13, 2017 Dec 31, 2016

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HCM (Nasdaq), HMDCF (OTC)
Incorporated in
Cayman Islands
Headquarters
Hong Kong
SEC filer status
Large accelerated filer
SEC CIK
1648257
Former names
Hutchison China MediTech Ltd (until Apr 29, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.